Funder: National Institutes of Health
Due Dates: June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | September 7, 2025 (AIDS) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision) | January 7, 2026 (AIDS) | February 5, 2026 (New) | March 5, 2026 (Renewal/Resubmission/Revision) | May 7, 2026 (AIDS) | June 5, 2026 (New) | July 5, 2026 (Renewal/Resubmission/Revision) | September 7, 2026 (AIDS) | October 5, 2026 (New) | November 5, 2026 (Renewal/Resubmission/Revision) | January 7, 2027 (AIDS) | Expiration: January 8, 2027
Funding Amounts: No budget cap; budgets must reflect actual project needs. Maximum project period: 5 years. Typical R01 NIH award size and duration apply.
Summary: Funds clinical trials testing interventions to expand cancer screening and preventive services in populations experiencing health disparities, with a focus on multi-level, community-engaged approaches.
Key Information: Clinical trial required. Projects must address barriers at ≥2 levels (e.g., patient, clinician, setting, community). NIH-designated disparity populations only.